Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 S2Medical B S2M Apr 24, 2025 0.01 -5.43   
 SAAB B SAABB Apr 24, 2025 425.45 +0.85   
 Safe at Sea SAFE Apr 24, 2025 1.05 -2.78   
 Safe Lane Gaming B SLGB Apr 24, 2025 1.45 -3.33   
 Safello Group SFL Apr 24, 2025 5.80 +3.94   
 Safeture SFTR Apr 24, 2025 5.60 0.00   
 Sagax A SAGAA Apr 24, 2025 216.70 +1.83   
 Sagax B SAGAB Apr 24, 2025 214.80 0.00   
 Sagax D SAGAD Apr 24, 2025 32.42 -0.08   
 SaltX Technology Holding B SALTB Apr 24, 2025 4.66 +1.30   
 Sampo A SDB SAMPOSDB Apr 24, 2025 94.90 -3.06   
 Samtrygg Group B SAMTB Apr 24, 2025 3.82 +9.14   
 Sandvik SAND Apr 24, 2025 199.80 +1.06   
 Saniona SANION Apr 24, 2025 7.32 +1.53   
 SARSYS-ASFT SARS Apr 24, 2025 0.75 -4.46   
 SaveLend Group YIELD Apr 24, 2025 1.61 +0.31   
 Saxlund Group SAXG Apr 24, 2025 10.40 0.00   
 SBB Norden B SBBB Apr 24, 2025 3.86 -0.46   
 SBB Norden D SBBD Apr 24, 2025 6.87 +2.16   
 SCA A SCAA Apr 24, 2025 130.00 -0.61   
 SCA B SCAB Apr 24, 2025 130.15 -0.72   
 ScandBook Holding SBOK Apr 24, 2025 38.80 +2.11   
 Scandi Standard SCST Apr 24, 2025 84.00 +0.60   
 Scandic Hotels Group SHOT Apr 24, 2025 73.00 +0.62   
 ScandiDos SDOS Apr 24, 2025 1.27 -1.93   
 Scandinavian Astor Group AB ASTOR Apr 24, 2025 26.34 -3.16   
 Scandinavian ChemoTech B CMOTECB Apr 24, 2025 1.44 0.00   
 Scandinavian Enviro Systems SES Apr 24, 2025 0.78 -3.35   
 Scandinavian Real Heart HEART Apr 24, 2025 13.95 -3.79   
 Scandion Oncology SCOL Apr 24, 2025 0.01 -7.14   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.